TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$23.83 USD
+0.50 (2.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $23.82 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
TG Therapeutics (TGTX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$32.86 | $49.00 | $8.00 | 40.85% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for TG Therapeutics comes to $32.86. The forecasts range from a low of $8.00 to a high of $49.00. The average price target represents an increase of 40.85% from the last closing price of $23.33.
Analyst Price Targets (7 )
Broker Rating
TG Therapeutics currently has an average brokerage recommendation (ABR) of 1.63 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.63 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Goldman Sachs | Corinne Johnson | Hold | Hold |
8/7/2024 | LadenburgThalmann | Matthew L Kaplan | Strong Buy | Strong Buy |
8/7/2024 | Cantor Fitzgerald & Co | Prakhar Agrawal | Strong Buy | Strong Buy |
8/6/2024 | H.C. Wainwright & Co. | Edward White | Strong Buy | Strong Buy |
7/8/2024 | B. Riley Securities | Mayank Mamtani | Strong Buy | Strong Buy |
5/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.63 |
ABR (Last week) | 1.63 |
# of Recs in ABR | 8 |
Average Target Price | $32.86 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 69 of 253 |
Current Quarter EPS Est: | 0.03 |
TGTX FAQs
TG Therapeutics, Inc. (TGTX) currently has an average brokerage recommendation (ABR) of 1.63 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for TG Therapeutics, Inc. (TGTX) is $32.86. The current on short-term price targets is based on 7 reports.
The forecasts for TG Therapeutics, Inc. (TGTX) range from a low of $8 to a high of $49. The average price target represents a increase of $37.89 from the last closing price of $23.83.
The current UPSIDE for TG Therapeutics, Inc. (TGTX) is 37.89%
Based on short-term price targets offered by seven analysts, the average price target for TG Therapeutics comes to $32.86. The forecasts range from a low of $8.00 to a high of $49.00. The average price target represents an increase of 40.85% from the last closing price of $23.33.